From: Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood
Controls | Converters | |
---|---|---|
Baseline (T1) | ||
N | 42 | 54 |
Gender (m/f) | 10/32 | 17/34 |
Age at baseline (mean ± SD) | 81.00 ± 3.11 | 82.31 ± 3.55 |
APOE4 carriers | 43% | 43% |
Follow-up (T2) | ||
N | 42 | 41 |
Gender (m/f) | 10/32 | 13/28 |
Age at baseline (mean ± SD) | 81.00 ± 3.11 | 82.01 ± 3.51 |
APOE4 carriers | 43% | 41% |